Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrianus C M Boon

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Plos Pathogens|June 14, 2019
Therapeutic efficacy of favipiravir against Bourbon virus in miceTraci L Bricker, Md Shafiuddin, Anshu P Gounder, et al.
Scientific Reports|October 26, 2019
ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challengesArijita Jash, You W Zhou, Diana K Gerardo, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamstersBaoling Ying, Tamarand L Darling, Pritesh Desai, et al.
The Journal of Experimental Medicine|March 8, 2018
<i>Irg1</i> expression in myeloid cells prevents immunopathology during <i>M. tuberculosis</i> infectionSharmila Nair, Jeremy P Huynh, Vicky Lampropoulou, et al.
Journal of Virology|July 10, 2015
Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae FamiliesAmelia K Pinto, Graham D Williams, Kristy J Szretter, et al.
Microbiology Spectrum|January 25, 2023
mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19Christina M Kackos, Sherri L Surman, Bart G Jones, et al.
Msphere|September 4, 2020
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell CultureChristian Shema Mugisha, Hung R Vuong, Maritza Puray-Chavez, et al.
Journal of Virology|February 13, 2015
An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionMark Zanin, Zhen-Yong Keck, G Jonah Rainey, et al.
Science (New York, N.Y.)|August 5, 2017
The microbial metabolite desaminotyrosine protects from influenza through type I interferonAshley L Steed, George P Christophi, Gerard E Kaiko, et al.
Nature Immunology|February 10, 2024
Mucosal vaccine-induced cross-reactive CD8<sup>+</sup> T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infectionBaoling Ying, Tamarand L Darling, Pritesh Desai, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Plos Pathogens|June 14, 2019
Therapeutic efficacy of favipiravir against Bourbon virus in miceTraci L Bricker, Md Shafiuddin, Anshu P Gounder, et al.
Scientific Reports|October 26, 2019
ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challengesArijita Jash, You W Zhou, Diana K Gerardo, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamstersBaoling Ying, Tamarand L Darling, Pritesh Desai, et al.
The Journal of Experimental Medicine|March 8, 2018
<i>Irg1</i> expression in myeloid cells prevents immunopathology during <i>M. tuberculosis</i> infectionSharmila Nair, Jeremy P Huynh, Vicky Lampropoulou, et al.
Journal of Virology|July 10, 2015
Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae FamiliesAmelia K Pinto, Graham D Williams, Kristy J Szretter, et al.
Microbiology Spectrum|January 25, 2023
mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19Christina M Kackos, Sherri L Surman, Bart G Jones, et al.
Msphere|September 4, 2020
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell CultureChristian Shema Mugisha, Hung R Vuong, Maritza Puray-Chavez, et al.
Journal of Virology|February 13, 2015
An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionMark Zanin, Zhen-Yong Keck, G Jonah Rainey, et al.
Science (New York, N.Y.)|August 5, 2017
The microbial metabolite desaminotyrosine protects from influenza through type I interferonAshley L Steed, George P Christophi, Gerard E Kaiko, et al.
Nature Immunology|February 10, 2024
Mucosal vaccine-induced cross-reactive CD8<sup>+</sup> T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infectionBaoling Ying, Tamarand L Darling, Pritesh Desai, et al.
Pageof 11